A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.

Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...

Mounjaro (tirzepatide) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as a liquid solution that you inject under your skin, typically once per week. Mounjaro ...

Despite the growing prevalence of aspirin use among patients starting warfarin, five of the nine randomized trials that specifically assessed the benefits and harms of combination warfarin plus ...